Navigation Links
Freezing Kidney Tumors Effective and Less Expensive Than Laparoscopy

Researchers have found that the nonsurgical image-guided treatment of kidney tumors – cryoablation – is as effective as the laparoscopic// technique in viable candidates. The research was presented at the Society of Interventional Radiology’s 32nd Annual Scientific Meeting.

The comparative trial shows that percutaneous cryoablation results in a slightly lower recurrence rate of the tumor, a shorter hospital stay, no major complications, and a 59.5 percent lower hospital cost than the laparoscopic treatment. During cryoablation argon gas enters the tip of the probe and extracts heat from the surrounding cells, resulting in an “ice ball” that freezes and kills the tumor. The nonsurgical treatment spares the majority of the healthy kidney tissue and can be repeated as often as needed. This interventional treatment had no major complications as opposed to the surgical group, which experienced complications in six percent of those studied.

The radiologist uses imaging to pinpoint the tumor, and then inserts the cryoprobe through the skin, similar to the way a biopsy is performed. This can be performed under general anesthesia, but is often possible with only local anesthesia and conscious sedation. By using imaging the radiologist can avoid going through any adjacent structures or harming healthy tissue. If necessary, adjacent structures can be displaced prior to the ablation to minimize collateral damage. Laparoscopy, on the other hand, requires general anesthesia, as well as multiple abdominal incisions to allow access for the surgical instruments. It is also associated with a longer recovery time.

“This early stage research indicates that percutaneous cryoablation in the appropriate patient population can effectively kill tumors, while also offering patients a shorter hospital stay, a faster recovery, and an excellent safety profile, all at a lower cost than laparoscopy,” noted study author J. Louis Hinshaw, M.D., of the Universit y of Wisconsin. “Unfortunately, not all patients are viable candidates for percutaneous ablation and we work closely with our urology colleagues to ensure that each patient receives the most appropriate treatment.”

The FDA has approved both radiofrequency ablation and cryoablation for use in soft tissue tumors, of which renal cell carcinoma is one.

“We are excited about this study because it offers patients with renal cell carcinoma a less traumatic treatment that can be repeated as needed,” Hinshaw added. “Depending on the stage of the disease, this procedure can be curative, but can also be used for palliative treatment in some settings.”


Related medicine news :

1. Embryo Freezing
2. New Technique Destroys Kidney Tumors By Freezing Them
3. Is Diabetes the Leading Cause of Kidney Failure in India
4. Kidney Stones - Interesting New Research implicates bacteria as its cause
5. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
6. New Dietary Approach To Manage Kidney Stones
7. Kidney cancer on the rise
8. Kidney function can be affected by lead exposure
9. Kidney Failure after Non-Kidney Transplants
10. Kidney Patients Risk Heart Attacks
11. Kidney Patients Risk Heart Attacks
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 26, 2016 ... value-based care operating models within the health care industry ... greater financial efficiency , Deloitte offers a suite ... key business issues impacting efficient cost optimization: labor resource ... , These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
Breaking Medicine Technology: